Glioma cancer stem cells induce immunosuppressive macrophages/microglia.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Neuro-Oncology

• Publication date

  2010-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/neuonc/noq082PMID 20667896PMCID PMC3098021
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glioma-Associated Cancer-Initiating Cells Induce Immunosuppression

  2010influential reference
• Inhibition of p-STAT3 Enhances IFN-α Efficacy against Metastatic Melanoma in a Murine Model

  2010cited by this paper
• TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients.

  2010cited by this paper
• Nuclear Factor-κB and Tumor-Associated Macrophages

  2010cited by this paper
• Immune therapeutic targeting of glioma cancer stem cells

  2010cited by this paper
• Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway

  2010cited by this paper
• Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy.

  2009cited by this paper
• PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.

  2009cited by this paper
• Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation.

  2009cited by this paper
• Antigen‐Specific T‐Cell Response from Dendritic Cell Vaccination Using Cancer Stem‐Like Cell‐Associated Antigens

  2009cited by this paper
• Elevated levels of MIC‐1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome

  2009cited by this paper
• Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB

  2009cited by this paper
• Site‐specific anti‐tumor immunity: Differences in DC function, TGF‐β production and numbers of intratumoral Foxp3+ Treg

  2009cited by this paper
• Toll‐Like Receptor Engagement Enhances the Immunosuppressive Properties of Human Bone Marrow‐Derived Mesenchymal Stem Cells by Inducing Indoleamine‐2,3‐dioxygenase‐1 via Interferon‐β and Protein Kinase R

  2009cited by this paper
• Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.

  2009cited by this paper
• CD133 (Prominin) Negative Human Neural Stem Cells Are Clonogenic and Tripotent

  2009cited by this paper
• M2 Macrophages Phagocytose Rituximab-Opsonized Leukemic Targets More Efficiently than M1 Cells In Vitro1

  2009cited by this paper
• STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells

  2009cited by this paper
• Squelching glioblastoma stem cells by targeting REST for proteasomal degradation.

  2009cited by this paper
• Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma.

  2008cited by this paper
• Expression and putative functions of GDF-15, a member of the TGF-beta superfamily, in human glioma and glioblastoma cell lines.

  2008cited by this paper
• CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.

  2008cited by this paper
• Macrophage activation and polarization.

  2008cited by this paper
• The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas

  2008cited by this paper
• Human Anti-Inflammatory Macrophages Induce Foxp3+GITR+CD25+ Regulatory T Cells, Which Suppress via Membrane-Bound TGFβ-11

  2008cited by this paper
• Astrocytic Regulation of Human Monocytic/Microglial Activation1

  2008cited by this paper
• Tumor‐infiltrating myeloid‐derived suppressor cells are pleiotropic‐inflamed monocytes/macrophages that bear M1‐ and M2‐type characteristics

  2008cited by this paper
• Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.

  2008cited by this paper
• Microglia-derived TGF-β as an important regulator of glioblastoma invasion—an inhibition of TGF-β-dependent effects by shRNA against human TGF-β type II receptor

  2008cited by this paper
• Toll-like receptor 4 mediates chronic restraint stress-induced immune suppression.

  2008cited by this paper
• Role of Stat3 in suppressing anti-tumor immunity.

  2008cited by this paper
• Molecular Cancer BioMed Central

  2008cited by this paper
• Macrophages and cancer.

  2008cited by this paper
• Swords into plowshares: IL-23 repurposes tumor immune surveillance.

  2007cited by this paper
• The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A.

  2007cited by this paper
• Crosstalk among Jak‐STAT, Toll‐like receptor, and ITAM‐dependent pathways in macrophage activation

  2007cited by this paper
• Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1

  2007cited by this paper
• A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients.

  2007cited by this paper
• Tumour immunology: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment

  2007cited by this paper
• Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions

  2007cited by this paper
• Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

  2006cited by this paper
• Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas.

  2006cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006cited by this paper
• Innate immune functions of microglia isolated from human glioma patients

  2006cited by this paper
• The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.

  2006cited by this paper
• Dual role of macrophages in tumor growth and angiogenesis

  2006cited by this paper
• Stat3 in Resident Macrophages as a Repressor Protein of Inflammatory Response1

  2005cited by this paper
• Neural stem cells and the origin of gliomas.

  2005cited by this paper
• Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity

  2005cited by this paper
• Impact of Tumor-Derived CCL2 on Macrophage Effector Function.

  2005cited by this paper
• The STATs of cancer — new molecular targets come of age

  2004cited by this paper
• CSF-1 regulation of the wandering macrophage: complexity in action.

  2004cited by this paper
• CCL2 (monocyte chemoattractant protein-1) and cancer.

  2004cited by this paper
• Erratum: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma (Cancer Research (October 2004) 64 (7011-7021)

  2004cited by this paper
• Tumour-educated macrophages promote tumour progression and metastasis

  2004cited by this paper
• Proliferative Assays for T Cell Function

  2004cited by this paper
• Microglia

  2004cited by this paper
• Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma

  2004cited by this paper
• Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria.

  2004cited by this paper
• IL-1 is required for tumor invasiveness and angiogenesis

  2003cited by this paper
• MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis.

  2002cited by this paper
• The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies

  2002cited by this paper
• Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-101

  2002cited by this paper
• Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy

  2001cited by this paper
• Role of microglia in glioma biology

  2001cited by this paper
• Secondary Lymphoid Tissue Chemokine Mediates T Cell-Dependent Antitumor Responses In Vivo1

  2000cited by this paper
• Tumor‐induced immune dysfunction: the macrophage connection

  1998cited by this paper
• IL‐10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3‐dependent and ‐independent pathways

  1998cited by this paper
• MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily.

  1997cited by this paper
• TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice.

  1995cited by this paper
• Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared.

  1995cited by this paper
• The origin and function of tumor-associated macrophages.

  1992cited by this paper
• Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin

  1988cited by this paper

• In vitro generated macrophages reflect the immunosuppressive phenotype of in vivo glioblastoma-associated macrophages

  2026cites this paper
• Modulation of Microglia Cell Phenotype by Semi-Allogeneic Cancer Vaccines

  2026cites this paper
• Prophylactic and therapeutic CSC-based vaccination reduced tumor growth, metastasis and enhanced survival in mouse model of breast cancer.

  2026cites this paper
• Neural stem cells and glioblastoma stem cells: redefining concepts.

  2026cites this paper
• Role of elevation of glycolysis in tumor-associated macrophages in glioblastoma immune evasion and therapeutic implications

  2026cites this paper
• Tumor‐Associated Macrophages as Therapeutic Targets: Deciphering Interaction Networks and Advancing Clinical Translation

  2026cites this paper
• A multi-omics atlas of CAF subtypes reveals apCAF–M2 macrophage interactions driving immune resistance in glioma

  2025cites this paper
• Xenoline-polarized macrophages as a physiologically relevant in vitro model of tumor-associated macrophages in glioblastoma

  2025cites this paper
• Glioma stem cells: drivers of tumor progression and recurrence

  2025cites this paper
• Neuroimmunology-driven CAR T-cell therapeutics for gliomas: translational challenges and clinical trial paradigm innovation.

  2025cites this paper
• Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities

  2025cites this paper
• Xenoline-polarized macrophages as an alternative in vitro model of tumor-associated macrophages in glioblastoma

  2025cites this paper
• Microglial and TREM2 dialogues in the developing brain.

  2025cites this paper
• The Importance of Cancer Stem Cells and Their Pathways in Endometrial Cancer: A Narrative Review

  2025cites this paper
• Inhibition of programmed cell death by melanoma cell subpopulations reveals mechanisms of melanoma metastasis and potential therapeutic targets

  2025cites this paper
• Harnessing the innate immune system for glioblastoma therapeutics.

  2025cites this paper
• Enhanced glioblastoma immunotherapy via SMAC mimetic dose escalation and TGFβ blockade

  2025cites this paper
• Loss of B3GAT1/HNK-1 disrupts glioma-CD8+ T cell immune synapse formation for immune escape.

  2025cites this paper
• Cancer stem cells and niches: challenges in immunotherapy resistance

  2025cites this paper
• Hunting glioblastoma recurrence: glioma stem cells as retrospective targets.

  2025cites this paper
• Reciprocal interactions between glioma and tissue-resident cells fueling tumor progression.

  2025cites this paper
• Immune factors and their role in tumor aggressiveness in glioblastoma: Atypical cadherin FAT1 as a promising target for combating immune evasion

  2025cites this paper
• Dysregulated Microglial Synaptic Engulfment in Diffuse Midline Glioma

  2025cites this paper
• Cancer Stem Cells and Tumor-Associated Macrophages: Interactions and Therapeutic Opportunities.

  2025cites this paper
• Docetaxel Administration via Novel Hierarchical Nanoparticle Reduces Proinflammatory Cytokine Levels in Prostate Cancer Cells

  2025cites this paper
• JAK2/STAT3 Signaling in Myeloid Cells Contributes to Obesity-Induced Inflammation and Insulin Resistance

  2025cites this paper
• Stress-induced pro-inflammatory glioblastoma stem cells secrete TNFAIP6 to enhance tumor growth and induce suppressive macrophages.

  2025cites this paper
• CTLA-4 and PD-1 combined blockade therapy for malignant melanoma brain metastases: mechanisms, challenges, and prospects

  2025cites this paper
• The curse of blood–brain barrier and blood–tumor barrier in malignant brain tumor treatment

  2025cites this paper
• Advances in stem cell-based therapeutic transfers for glioblastoma treatment

  2025cites this paper
• From hormonal immunomodulation to glioblastoma therapy: the emerging role of Ouabain

  2025cites this paper
• Hydrogen sulfide inhibits recruitment of monocyte-derived tumor associated macrophages in glioblastoma by downregulating CXCL12

  2025cites this paper
• Harnessing the role of transforming growth factor-β in glioblastoma: a focus on phytochemicals

  2025cites this paper
• Regulation of Cancer Stem Cells in the Tumor Microenvironment

  2025cites this paper
• Emerging macrophage-based therapies for cancer: a review of preclinical and clinical advances

  2025cites this paper
• Microglial Inflammatory Response in the Glioblastoma Microenvironment in Preclinical Models

  2025cites this paper
• Emerging Frontiers in Neuro-Oncology: Insights into Extracellular Vesicle-Driven Tumor Mechanisms and Nanotherapeutic Strategies

  2025cites this paper
• Les microtubes tumoraux dans les gliomes : mécanismes, implications dans le développement tumoral et perspectives de recherche

  2025cites this paper
• First-in-child phase I trial of p-STAT3 inhibitor WP1066 in pediatric brain tumor patients

  2025cites this paper
• Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction

  2025influential citation
• Cancer Stem Cells Decide the Fate of Cancer Immunotherapy by Remodeling Tumor Microenvironment

  2025cites this paper
• Hypoxic Secretome and Exosomes Derived From Human Glioblastoma Cells (U87MG) Promote Protumorigenic Phenotype of Microglia in Vitro

  2025cites this paper
• Within and beyond the tumor: Mechanisms of glioblastoma-induced immunosuppression

  2025cites this paper
• Eradicating Cancer Stem Cells Using High Linear Energy Transfer Radiation Therapy Part 2: LET Painting and Other Advanced Techniques

  2025cites this paper
• Glioblastoma Stem Cells at the Nexus of Tumor Heterogeneity, Immune Evasion, and Therapeutic Resistance

  2025influential citation
• Exploring tumor-associated macrophages in glioblastoma: from diversity to therapy

  2025cites this paper
• Antibiotics treatment promotes vasculogenesis in the brain of glioma-bearing mice

  2024cites this paper
• Investigating the mechanisms of drug resistance and prognosis in ovarian cancer using single-cell RNA sequencing and bulk RNA sequencing

  2024cites this paper
• Involvement of microglia‐expressed MS4A6A in the onset of glioblastoma

  2024cites this paper
• Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives

  2024cites this paper
• Targeted Cancer Stem Cell Therapeutics: An Update.

  2024cites this paper
• Transglutaminase 2 function in glioblastoma tumor efferocytosis

  2024cites this paper
• Glioma–Immune Cell Crosstalk in Tumor Progression

  2024cites this paper
• Nanotechnology Meets Stem Cell Therapy for Treating Glioblastomas: A Review

  2024cites this paper
• Tumor associated microglia/macrophages utilize GPNMB to promote tumor growth and alter immune cell infiltration in glioma

  2024cites this paper
• Flavonoid Rutin Presented Anti-Glioblastoma Activity Related to the Modulation of Onco miRNA-125b Expression and STAT3 Signaling and Impact on Microglia Inflammatory Profile

  2024cites this paper
• Potential roles for efferocytosis in glioblastoma immune evasion

  2024cites this paper
• FSTL1 Sustains Glioma Stem Cell Stemness and Promotes Immunosuppressive Macrophage Polarization in Glioblastoma.

  2024cites this paper
• Co-evolution of glioma and immune microenvironment

  2024cites this paper
• Neuroinflammation in Glioblastoma: The Role of the Microenvironment in Tumour Progression.

  2024cites this paper
• Glioblastoma and Immune Checkpoint Inhibitors: A Glance at Available Treatment Options and Future Directions

  2024cites this paper
• Expression features of targets for anti-glioma CAR-T cell immunotherapy

  2024cites this paper
• Advances in CAR-T therapy for central nervous system tumors

  2024cites this paper
• Integration of single-cell sequencing and bulk transcriptome data develops prognostic markers based on PCLAF+ stem-like tumor cells using artificial neural network in gastric cancer

  2024cites this paper
• Updates in Microglial Research with Respect to Brain Cancer

  2024cites this paper
• Navigating the immunosuppressive brain tumor microenvironment using spatial biology

  2024cites this paper
• Glioblastoma: A molecular insight into current discoveries and treatment directions

  2024cites this paper
• IL-13Rα2/TGF-β bispecific CAR-T cells counter TGF-β-mediated immune suppression and potentiate anti-tumor responses in glioblastoma.

  2024cites this paper
• The tumour microenvironment, treatment resistance and recurrence in glioblastoma

  2024cites this paper
• Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment

  2024cites this paper
• Extracellular vesicles and cancer stem cells: a deadly duo in tumor progression

  2024cites this paper
• Polarization of M2 Tumor-Associated Macrophages (TAMs) in Cancer Immunotherapy.

  2024cites this paper
• Non-targeted effects of radiation therapy for glioblastoma

  2024cites this paper
• Microglia in Glioblastomas: Molecular Insight and Immunotherapeutic Potential

  2024cites this paper
• Phagocytosis Checkpoints in Glioblastoma: CD47 and Beyond

  2024cites this paper
• Role of glioma stem cells in promoting tumor chemo- and radioresistance: A systematic review of potential targeted treatments

  2024cites this paper
• The dual role of POSTN in maintaining glioblastoma stem cells and the immunosuppressive phenotype of microglia in glioblastoma

  2024cites this paper
• Tumor-associated macrophages: an effective player of the tumor microenvironment

  2023cites this paper
• Investigational treatment strategies in glioblastoma: progress made and barriers to success

  2023cites this paper
• The tumor micro-environment in pediatric glioma: friend or foe?

  2023cites this paper
• The role of angiogenic growth factors in the immune microenvironment of glioma

  2023cites this paper
• Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies

  2023cites this paper
• Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity

  2023cites this paper
• Decoding meningioma heterogeneity and neoplastic cell—macrophage interaction through single-cell transcriptome profiling across pathological grades

  2023cites this paper
• Signal-transducing adaptor protein 1 (STAP1) in microglia promotes the malignant progression of glioma

  2023cites this paper
• Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance

  2023cites this paper
• The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma

  2023cites this paper
• Local immunotherapy of glioblastoma: A comprehensive review of the concept.

  2023cites this paper
• Interactions between microglia and glioma in tumor microenvironment

  2023cites this paper
• The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma

  2023cites this paper
• The Glioblastoma Landscape: Hallmarks of Disease, Therapeutic Resistance, and Treatment Opportunities

  2023cites this paper
• Estimating the survival rate in glioblastoma multiforme patients who received a peptide vaccine: a systematic review and meta-analysis.

  2023cites this paper
• Modulating the polarization phenotype of microglia - a valuable strategy for central nervous system diseases.

  2023cites this paper
• Interdependencies of the Neuronal, Immune and Tumor Microenvironment in Gliomas

  2023influential citation
• Tyrosine metabolic reprogramming coordinated with the tricarboxylic acid cycle to drive glioma immune evasion by regulating PD‐L1 expression

  2023cites this paper
• Intra- and Intertumoral Microglia/Macrophage Infiltration and Their Associated Molecular Signature Is Highly Variable in Canine Oligodendroglioma: A Preliminary Evaluation

  2023cites this paper
• Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions

  2023influential citation
• PERK‐Mediated Cholesterol Excretion from IDH Mutant Glioma Determines Anti‐Tumoral Polarization of Microglia

  2023cites this paper
• Cancer Stem Cells in Tumours of the Central Nervous System in Children: A Comprehensive Review

  2023cites this paper
• Cell-specific crosstalk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone

  2023cites this paper